Abstract Osteoarthrosis (OA) is a common cause of musculoskeletal disability characterized by late-onset degeneration of articular cartilage. Although several candidate genes have been reported, susceptibility genes for OA remain to be determined. Hereditary osteochondral dysplasias produce severe, early-onset OA and hence are models for common idiopathic OA. Among them are pseudoachondroplasia and multiple epiphyseal dysplasia, both of which are caused by mutations in the cartilage oligomeric matrix protein (COMP) gene. Therefore, COMP may be a susceptibility gene for OA. We screened for polymorphisms by direct sequencing of all exons of the COMP gene with their flanking intron sequences and the promoter region. We identified 16 polymorphisms, of which 12 were novel. Using six polymorphisms spanning the entire COMP gene, we examined the association of COMP in Japanese patients with OA of the knee and hip joints. Genotype and allele frequencies of the polymorphisms were not significantly different between OA and control groups, and there was no significant difference in haplotypes. These results do not support an association between COMP and OA in the Japanese population.
Introduction
Osteoarthrosis (OA) is a common cause of musculoskeletal disability related to aging and characterized by late-onset degeneration of articular cartilage. The prevalence of OA increases with age, and 10% of the elderly are affected with OA (Felson and Zhang 1998) . A genetic contribution to OA has been suggested in several epidemiological studies (Stecher 1941; Kellgren et al. 1963; Spector et al. 1996; MacGregor et al. 2000) . Genetic factors comprise the essential components of the etiology of OA; however, susceptibility genes for OA remain to be determined.
Many osteochondral dysplasias with Mendelian inheritance manifest involvement of articular cartilage and OA. These heritable diseases are models for OA as a common disease in a general population, and mutations in the causal gene of these diseases are clues to the susceptibility genes for OA. Among these osteochondral dysplasias that are associated with OA are pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). PSACH is characterized by severe disproportionate dwarfism, early-onset OA, and spinal deformity, whereas MED is characterized by early-onset OA and dysplasia of epiphyses with lesssevere dwarfism. PSACH and MED are allelic, and are caused by mutations in the cartilage oligomeric matrix protein (COMP) gene (Briggs et al. 1995; Hecht et al. 1995) .
Mutations in the COMP gene produce a phenotypic gradation, from severe PSACH to mild MED (Ikegawa et al. 1998) . Late-onset milder MEDs are occasionally indistinguishable from common OA without information of posi-tive family history and symmetric involvement of multiple joints (Spranger et al. 1974) . Furthermore, a mutation in the C-terminus of COMP produces a normal height individual with skeletal abnormalities, including early OA (Briggs et al. 1998) . These findings lead us to the hypothesis that OA as a common disease might be at the mild end of the phenotypic gradation produced by COMP mutations.
In the present study, we ascertained the sequences of the exons and exon-intron boundaries and identified 16 polymorphisms in the COMP gene. We investigated whether these polymorphisms were associated with OA of the knee (KOA) and hip (HOA) joints in Japanese.
Subjects and methods

Subjects
A total of 402 OA patients (195 KOA and 207 HOA) and 228 control individuals were included in this cross-sectional multi-center study. All individuals visited hospitals for treatment and agreed to participate in this study. Ethical approval was obtained from the ethical committee of each participating institution, and a written informed consent was obtained from all subjects.
KOA was diagnosed based on clinical symptoms and radiological examinations. Inclusion criteria for KOA were (1) age 50 years or more; (2) presence of symptoms, i.e. pain, claudication, and so on; (3) narrowing of the articular joint space; and (4) formation of osteophytes on one or both knees. HOA was diagnosed by clinical symptoms and radiological findings of narrowing of the joint space and/or osteophytes of the hip joint. Because a dysplastic hip is a major cause and predisposing factor of HOA in Japan (Nakamura et al. 1989) , individuals with a dysplastic hip (center-edge angle Ͻ25° or acetabular angle Ͼ25° in the antero-posterior radiograph of the hip) were also included. All X-ray films were read by expert observers (A.F. for KOA and Y.T. for HOA). Most control individuals were patients with ossification of the posterior longitudinal ligament of the spine (OPLL). Genomic DNA of all individuals was extracted from 20ml of peripheral blood using a Genomix kit (Talent, Trieste, Italy).
Determination of genomic structure and sequences of exon-intron boundaries Genomic structure of COMP was determined by comparing published genomic and cDNA sequences (GenBank accession No. L32137) and was confirmed by direct sequencing of polymerase chain reaction (PCR) products from genomic DNA. PCR primers for exons 8-14 of COMP were as previously described (Ikegawa et al. 1998) . Primers for the promoter region and for exons 1-7 and 14-19 are listed in Table 1 .
PCR was performed with the Takara exTaq system (Takara Shuzo, Otsu, Japan) according to the instructions of the manufacturer in a total volume of 25µl, using as templates 50-100ng of each genomic DNA sample. PCR conditions were as follows: initial denaturation (94°C, 2min) followed by 35 cycles of denaturation (94°C, 30s), annealing (55°C-63°C according to the Tm of the primers, 30s), extension (72°C, 30s), and final extension (72°C, 5 min). PCR products were purified by Ultrafree-MC (Millipore, Bedford, MA, USA) and sequenced directly with an ABI 3700 automated sequencer and a Prism-Ready Reaction DyeDeoxy-Terminator Cycle-Sequencing Kit (ABI, Foster City, CA, USA). 
Identification of polymorphisms
Sequence variations in the coding regions and flanking noncoding regions of the COMP gene and in the 2.7-kb promoter region were examined by direct sequencing of the PCR products from genomic DNA. More than 32 chromosomes from unrelated individuals were examined.
Genotyping
Single-nucleotide polymorphisms (SNPs) were genotyped with a fluorescence-based 5Ј-nuclease detection assay, or TaqMan assay (Holland et al. 1991; Livak et al. 1995) , using as templates 10 ng of each genomic DNA sample in a total volume of 15 µl. PCR primers and probes for the TaqMan assay are listed in Table 2 . Amplification conditions were as follows: initial activation (at 50°C, 2min and then at 95°C, 10 min), followed by 40 cycles of denaturation (95°C, 15s), annealing, and extension (62°C, 1 min). After PCR amplification, fluorescence was read by an ABI 7700 Sequence Detector. A tetranucleotide repeat locus in intron 9 was amplified using a primer set of COMPe9i10/fl (5Ј-GTTCTTCTTT CGCCCCTCCTAGACC-3Ј) labeled with 6-FAM and COMPe9i10/n (5Ј-GGGTCCCCAATGAAAAGGTA-3Ј) and electrophoresed with the ABI 3700 automated sequencer. Alleles were sized and genotyped using a Genescan (version 3.5, ABI) and a Genotyper (version 3.7, ABI).
For SP15, the genotype was determined by PCR amplification and subsequent NaeI (Takara, Tokyo, Japan) restriction-endonuclease digestion of a 480-bp fragment. The PCR products were digested for 12 h with 2 U of NaeI per microgram of DNA, at 37°C, then electrophoresed on 4% NuSieve GTG agarose gels (BMA, Rockland, ME, USA).
Association study
Polymorphic loci for the association study were selected by the following criteria: (1) Allelic frequency, i.e., common polymorphisms were given priority; and (2) interval of the loci, i.e., physical distance between two neighboring polymorphic sites was within 6 kb. Allele frequencies were calculated for all polymorphic loci, and genotype frequencies for all SNPs. A -squared test was performed comparing each OA group and the control group. The odds ratio of the minor alleles was also calculated with a 95% confidential interval. Maximum-likelihood haplotype frequencies were calculated using an expectation-maximization algorithm (Excoffier and Slatkin 1995) . Fisher's exact test of population differentiation was performed, comparing haplotype frequencies between each OA group and the control group (Rousset and Raymond 1995) . Haplotypes were analyzed using Arlequin software (http://anthro.unige.ch/arlequin/).
Results
Nucleotide sequences of exon-intron boundaries
The entire exons and exon-intron boundaries of the COMP gene as well as the 2.7-kb promoter region were amplified from genomic DNA and sequenced directly. Sequences of the exon-intron boundaries predicted from the database were confirmed by sequencing the PCR products from genomic DNA, which all conformed to the AG-GT rule (Table 3) .
Identification of polymorphisms
A total of 16 polymorphisms, 14 SNPs, one dinucleotide repeat, and one tetranucleotide repeat were detected 
FAM-CGTGGGCCACCAGAGCCC-MGB SNP, single-nucleotide polymorphism (Table 4) . Twelve of the polymorphisms were novel. A previously reported cSNP, c.1755G/A (Briggs et al. 1998) was not found in 112 chromosomes. Eight polymorphisms were identified in the promoter region of the COMP gene, two of which were within Alu repeats that extended 400 to 600 bp upstream from the translation start site. Three silent cSNPs were identified.
Association and haplotype analyses
The size of the COMP gene is about 8.5 kb. According to the selection criteria previously mentioned, five SNPs and one tetranucleotide repeat (Ϫ1417C/G in the promoter region, c.279C/A in exon 4, IVS5ϩ76T/C, the tetranucleotide repeat in intron 9, IVS16Ϫ45C/T, and IVS18Ϫ40T/C) were used for the association study. The mean interval of the markers was 2.1 kb (range, 0.9-3.5 kb). The distribution of the five SNPs in the KOA, HOA, and control groups is shown in Table 5 . Observed genotype frequencies in these three groups were all in HardyWeinberg equilibrium. Allele and genotype frequencies between the OA and control groups did not differ significantly for any polymorphic loci. The locus with highest significance was SP9 in the HOA group ( 2 ϭ 3.79, P ϭ 0.06). Although polymorphisms in individuals with HOA carrying the minor allele of SP9 were screened, no polymorphisms other than those in the first screen were found. A total of 19 alleles were identified in the tetranucleotide repeat polymorphism. Because 13 of the alleles were individually very rare, they were pooled and subjected to the analysis. Allele frequencies in the KOA group did not differ significantly from the control group ( 2 ϭ 0.80, P ϭ 0.67), nor did they in the HOA group ( 2 ϭ 1.03, P ϭ 0.60). Haplotype analysis revealed that one major haplotype carrying each major allele was dominant in each group. Haplotype frequencies of the KOA and HOA groups were not different from those of the control subjects (Fisher's exact test P was 0.98 for the KOA group and 0.57 for the HOA group).
Discussion
We hypothesize that COMP is a candidate gene for OA. Histology of OA reveals qualitative and quantitative abnormalities of the extracellular matrix of the articular cartilage, which is mainly composed of collagens and non-collagenous proteins. COMP is a major component of the latter (Hedbom et al. 1992) and is thought to play a major role in development and homeostasis of the cartilage (DiCesare et al. 1994) . The association of OA with COL2A1, which encodes type II collagen, the major collagen of the articular cartilage, has been reported (Knowlton et al. 1990 ). Hence, it is reasonable to speculate that abnormal COMP, another major component of the cartilage matrix, could also cause OA. Actually, the COMP mutation produces early-onset OA in PSACH and MED.
In this study, we identified 16 polymorphisms, including 12 novel ones, in the COMP gene. We set the maximal interval between the marker loci to less than 6 kb, because a simulation study suggests that the useful range of linkage disequilibrium (LD) in the general population is as short as 3 kb (Kruglyak 1999) , which is to our knowledge the shortest range proposed. Estimation of LD based on real data has usually given broader ranges (Clark et al. 1998; Abecasis et al. 2001) . Using this dense set of polymorphisms, we investigated the association between the COMP genotypes and the prevalence of OA of the knee and hip joint in the Japanese population. However, we could not find evidence for a positive association between the COMP gene and the two types of OA.
Our study has several limitations. The first is the range of the genomic region screened for polymorphisms. We detected polymorphisms in the entire exons and in the exonintron boundary portions of the introns, but not elsewhere in the introns. Intronic polymorphisms that escaped detection may affect the prevalence of OA, although haplotype analysis results were negative for that hypothesis.
The second is the number of chromosomes screened for polymorphisms. We used at least 32 chromosomes for detection. That number guaranteed identification of sequence variations with frequencies of Ͼ10% (relatively common Genotypes "11" and "22" are homozygotes of major and minor alleles, respectively Genotype "12" is a heterozygote of major and minor alleles Alleles 1 and 2 are major and minor alleles, respectively polymorphisms) at more than 95% probability. We aimed to isolate relatively common polymorphisms because uncommon polymorphisms require a huge number of samples for detection of association and are in practice uninformative (Risch and Merikangas 1996) . In our attempt to detect PSACH and MED mutations using genomic DNA and cDNA, we found no other exonic polymorphisms, even though the entire coding region of COMP was examined in 19 patients (Mabuchi et al. to be published). The third limitation is that loci with significant association may exist in a region more proximal or distal to the region we screened, i.e., in the 5Ј or 3Ј flanking regions. A recent study of chondrocyte-specific expression of the murine COMP gene reveals that two regulatory elements in the 5Ј flanking region and the proximal element are located as far as 1.9 kb upstream from the transcription start site (Issack et al. 2000) . However, our search covered the corresponding region of the human COMP gene. Polymorphisms we identified in the promoter region were in considerable LD and were well represented by the Ϫ1417C/G polymorphism.
It is of note that the estimated haplotypes in our study include one major and several minor ones. If the major haplotype carries a significant polymorphism with low frequency, it might mask contributions by other significant polymorphisms in the case-control study. However, polymorphisms other than those examined in our study should not exist, or even if they do exist, their frequency would be very low.
The absence of positive association in the present study is consistent with previous linkage studies. Mustafa et al. [2000] reported a P value of Ͻ0.05 in a stratified linkage analysis using D19S215, but did not confirm the relationship by multiple testing. There is no suggestion of a linkage in a sibling-pair study of chromosome 19, which carries the COMP gene [Loughlin et al. 1999] . Taken together with our result, COMP is probably not a major cause of OA. The limited sample size of our study might preclude detection of a small contribution of COMP polymorphism(s) to a small number of OA patients. This possibility will be clarified by future large-scale association studies.
